埃格列净 T4999
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 1210344-57-2 | ¥496.00 | 询底价 |
5 mg | 1210344-57-2 | ¥1,220.00 | 询底价 |
10 mg | 1210344-57-2 | ¥1,860.00 | 询底价 |
500 mg | 1210344-57-2 | ¥13,300.00 | 询底价 |
200 mg | 1210344-57-2 | ¥8,980.00 | 询底价 |
25 mg | 1210344-57-2 | ¥3,150.00 | 询底价 |
1 mL | 1210344-57-2 | ¥1,330.00 | 询底价 |
50 mg | 1210344-57-2 | ¥4,630.00 | 询底价 |
100 mg | 1210344-57-2 | ¥6,590.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Ertugliflozin
描述: Ertugliflozin (PF-04971729) 是选择性的、口服有效的钠离子依赖的葡萄糖协同转运蛋白2 (SGLT2) 抑制剂,对h-SGLT2 的IC50值为 0.877 nM。Ertugliflozin 在2型糖尿病中有研究价值。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (114.45 mM)
关键字: MK8835 | inhibit | MK 8835 | Inhibitor | PF04971729 | PF 04971729 | SGLT | Sodium-dependent glucose cotransporters | Ertugliflozin
相关产品: Tofogliflozin (hydrate) | KGA-2727 | Ipragliflozin | O-Desethyl Dapagliflozin | Dapagliflozin | Canagliflozin | Licogliflozin | Picraline | SGLT inhibitor-1 | IRAK inhibitor 4 trans
相关库: Drug Repurposing Compound Library | Glutamine Metabolism Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | GPCR Compound Library | Inhibitor Library | Highly Selective Inhibitor Library | Anti-Cancer Approved Drug Library | EMA Approved Drug Library
埃格列净 T4999信息由TargetMol中国为您提供,如您想了解更多关于埃格列净 T4999报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途